Millipore Sigma Bio-Expo Live November 2025: Downstream Bioprocessing

The stability and resilience of the biopharmaceutical supply chain are paramount. In this presentation, we explore a new approach to manufacturing essential components, specifically filters, by integrating global expertise with localized production.

Discover how the recently opened, climate-neutral Blarney facility in Ireland strengthens supply chain integrity for critical bioprocessing materials. We detail the benefits of a global-local hybrid manufacturing infrastructure, providing greater flexibility and reduced lead times. Learn about the sustainable design features that make the Blarney site climate-neutral, setting a new standard for responsible manufacturing in the life sciences. We also examine the best-in-class filtration technologies produced at the facility and their advantages for various biopharma applications.

Understand how these advancements impact your operations and enhance supply chain reliability. Watch the presentation to explore the future of essential bioprocessing component production.